MedPath

Comparison of the effectiveness of anti-anxiety medication (buspirone and sertraline) on anxiety and gastrointestinal symptoms of functional dyspepsia patients

Phase 3
Recruiting
Conditions
Functional dyspepsia.
Functional dyspepsia
Registration Number
IRCT20210831052349N1
Lead Sponsor
Birjand University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
141
Inclusion Criteria

Willingness to participate in the study after fully explaining the objectives of the research and the disadvantages and advantages of the methods
not receiving psychological therapies before entering the study
No alcohol and drugs
Absence of danger signs such as gastrointestinal bleeding, blood in the stool, fever, weight loss, anemia, nocturnal diarrhea, severe heartburn
No psychotic disorder and personality disorder
Possibility to keep the type and amount of drug used during the research period if the drug is used
No other organic disease
Lack of other structural or functional gastrointestinal disorders

Exclusion Criteria

Having psychotic disorder or other gastrointestinal disorders
Existence of danger signs in the patient (such as gastrointestinal bleeding, blood in the stool, fever, weight loss, anemia, nocturnal diarrhea, severe heartburn, etc.)
Having complete criteria for personality disorder

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety score in Beck questionnaire. Timepoint: at the beggining (day 0),day 30,day 90. Method of measurement: Beck anxiety questionnaire.
Secondary Outcome Measures
NameTimeMethod
pper gastrointestinal symptoms severity questionnaire PAGI-SYM. Timepoint: At the beggining (day 0), day 30, day 90. Method of measurement: 20-item PAGI-SYM symptom severity questionnaire.
© Copyright 2025. All Rights Reserved by MedPath